GhassanEEl-HaddadMD

Senior Member, Interventional Radiology, Section Head of Radionuclide Therapy Program, Moffitt Cancer Center Associate Professor, Radiology and Oncological Sciences, University of South Florida

Join to view full profile

Dr. El-Haddad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. El-Haddad's full profile

Already have an account?

Office
12902 Magnolia Dr
Tampa, FL 33612
Phone+1 813-745-1598

Summary

Dr. Ghassan El-Haddad is a radiologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Lebanese University School of Medicine and has been in practice 16 years. He specializes in nuclear medicine and vascular & interventional radiology.

Education & Training

University of Pennsylvania Health SystemFellowship, Interventional Radiology - Independent, 2011 - 2012
Quinnipiac University Frank H. Netter MD School of Medicine/St VIncent's Medical CenterResidency, Radiology-Diagnostic, 2008 - 2012
University of Pennsylvania Health SystemResidency, Nuclear Medicine, 2003 - 2006
SUNY Upstate Medical UniversityInternship, Internal Medicine, 2002 - 2003
Lebanese University School of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2012 - 2026
LA State Medical License 2006 - 2012
PA State Medical License 2003 - 2012
MI State Medical License 2005 - 2009
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Interventional Radiology and Diagnostic Radiology

Clinical Trials

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma Start of enrollment: 2016 Mar 04
Active, not recruiting
Phase 2
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver Start of enrollment: 2016 Mar 01
Active, not recruiting
Phase 2
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2018 May 29
Completed
Phase 3

Publications & Presentations

PubMed

Multivariable models of outcomes with [Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial.
Ken Herrmann, Andrei Gafita, Johann S de Bono, Oliver Sartor, Kim N Chi
Eclinicalmedicine. 2024-11-01
Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors.
Adam Alayli, Hoang Ngo, Dhiraj Sikaria, Altan Ahmed, Elias Salloum
Cancers. 2024-07-30
2 citations
Hepatic Radioembolization: A Multistep Theragnostic Procedure.
K Ramdhani, Marnix G E H Lam, Arthur J A T Braat, Maarten L J Smits, Ghassan El-Haddad
PET Clinics. 2024-07-01

Journal Articles

Melanocortin 1 Receptor Targeted Alpha-Particle Therapy for Metastatic Uveal Melanoma.
Tafreshi NK, Tichacek CJ, Pandya DN, Doligalski ML, Budzevich MM, Kil H, Bhatt NB, Kock ND, Messina JL, Ruiz EE, Delva NC, Weaver A, Gibbons WR, Boulware DC, Khushalan..., J Nucl Med. 2019 Feb 7., 2/2019